Global Biosimilar Monoclonal Antibodies Forecast 2017-2027

NEW YORK, July 5, 2017 /PRNewswire/ -- Report Details
The global biosimilar monoclonal antibodies market is expected to grow at a CAGR of 9.6% in the second half of the forecast period. The market is expected to grow at a CAGR of 23.8% from 2015-2027. The market is estimated at $4.2bn in 2020 and $7.9bn in 2027.

Read the full report: http://www.reportlinker.com/p04974736/Global-Biosimilar-Monoclonal-Antibodies-Forecast.html


How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 204-page report you will receive 72 tables and 72 figures – all unavailable elsewhere.

The 204-page report provides clear detailed insight into the global biosimilar monoclonal antibodies market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Biosimilar Monoclonal Antibodies Market forecasts from 2017-2027

• Along with revenue prediction for the overall world market for biosimilar monoclonal antibodies, our investigation shows forecasts to 2027 for the market segmented by compound:
- Infliximab
- Rituximab
- Abciximab
- Trastuzumab
- Adalimumab
- Bevacizumab

• This report also shows revenue to 2027 for individual biosimilar mAb products in the market:
- Remsima/Inflectra
- Infimab
- Reditux
- BI695500
- CT-P10
- BI695501
- FKB327
- FKB238
- Mabtas
- AcellBia
- Maball
- Clotinab
- Abcixirel
- BCD-022
- BCD-021
- Herzuma
- CANMAB/Hertraz

• Our analyses show individual revenue forecasts to 2027 for these regional and national markets:
- The US Biosimilar mAb Market
- Japanese Biosimilar mAb Market
- EU5 Biosimilar mAb Markets
- BRIC and South Korea Biosimilar mAb Markets
- Rest of the World Biosimilar mAb Market

Read the full report: http://www.reportlinker.com/p04974736/Global-Biosimilar-Monoclonal-Antibodies-Forecast.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-biosimilar-monoclonal-antibodies-forecast-2017-2027-300483646.html

SOURCE Reportlinker